Ratings Moves: IMOS...
Health Care: Drugs
Zogenix Inc. (ZGNX: NASDAQ)
$1.57 -0.03 | -1.88%
05/20/13 - 03:59 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 1.60 |
| 52 Week High | 3.30 |
| 52 Week Low | 1.11 |
| Avg. Daily Vol. (Mil) | 1.21 |
| Beta (3 year) | 2.68 |
| Share Related Items | |
| Mkt Cap (Mil) | 161.29 |
| Shares Out (Mil) | 100.81 |
| Float (Mil) | 40.67 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 4.89 |
| Price/Book | 0.00 |
| Price/Cash Flow | -2.00 |
| Per Share Data | |
| Earnings | -0.64 |
| Sales | 0.33 |
| Book Value | 0.00 |
| Cash Flow | -0.82 |
| Business Summary | |
|---|---|
| Zogenix, Inc. is a pharmaceutical company, engaged in the commercializing and developing products for the treatment of central nervous system disorders and pain. | |
| General Information | |
| 12400 High Bluff Drive
Suite 650 San Diego, CA 92130 |
|
| www.zogenix.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 149 | |
| CEO: Roger L. Hawley | |
| Short Interest | |
| Current Month (Mil) | 7.04 |
| Previous Month (Mil) | 6.94 |
| Short Interest Ratio (Days) | 14.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -130.60 |
| Return on Investments | -363.00 |
| Profitability | |
| Gross Margin | 50.10 |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with ZGNX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- UserMy stocks
- UserJaheer
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
Latest ZGNX Headlines from TheStreet
- Zogenix And Battelle To Present Positive, New Data Demonstrating Value Of Needle-Free Injection For Biologics 05.20.13 | 07:05 am
- Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin 05.10.13 | 07:05 am
- Zogenix Reports First Quarter 2013 Financial Results 05.09.13 | 04:05 pm
- Zogenix Announces Conference Call And Webcast To Present First Quarter 2013 Financial Results 05.03.13 | 07:05 am
- Zogenix Reports Positive Top-Line Results From Extended Relday(TM) Phase 1 Clinical Trial 05.02.13 | 07:05 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- Zogenix And Battelle Extend DosePro Co-Marketing Partnership 03.27.13 | 08:03 am
- Zogenix Reports Fourth Quarter And Full Year 2012 Financial Results 03.15.13 | 07:03 am
- Zogenix Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2012 Financial Results 03.07.13 | 07:03 am
- Zogenix Provides Update On Zohydro(TM) ER Regulatory Review 02.26.13 | 08:02 pm
Press Releases for ZGNX
- DURECT Announces Positive Results From Reldayâ¿¢ Phase 1 Clinical Trial - PR Newswire 01.03.13 | 07:01 am
- Fast-Acting Migraine Treatment Highlighted During National Migraine Awareness Month - PR Newswire 06.06.11 | 08:06 am
Partner Headlines for ZGNX
- Zogenix Says FDA Panel Will Review Zohydro on Dec. 7th - Benzinga 11.08.12 | 09:11 am
- 3 Best Biotech Stocks For This Week (Part V) - Seeking Alpha 10.08.12 | 09:10 am
- Healthcare Business Review: Sarepta Shoots Into Outer SPACE, Roche Gets GOOD News - Wall St. Cheat Sheet 07.25.12 | 08:07 am
- Earnings Preview: Covidien - Analyst Blog - Zacks 07.23.12 | 10:07 am
- Healthcare Biz Review: Vivus' Second TRY, Intuitive Surgical's PROSPECTS - Wall St. Cheat Sheet 07.16.12 | 12:07 pm
- Benzinga's Microcap Movers for Friday July 13, 2012 - Benzinga 07.14.12 | 04:07 pm
- Company News for March 12, 2012 - Corporate Summary - Zacks 03.12.12 | 10:03 am
- Zogenix: Smart Biotech Buy Before Earnings - Seeking Alpha 03.05.12 | 07:03 am
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- Biotech Catalysts for Third Quarter - Seeking Alpha 06.24.11 | 06:06 pm
